10mg Mounjaro to Wegovy UK - Compare Prices & Switch

Clinically Proven UK Registered Pharmacy

Cheapest 10mg Mounjaro to Wegovy UK - Compare Prices

Compare 10mg Mounjaro to Wegovy at the cheapest UK price from £225.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £225.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Switching from 10mg Mounjaro to Wegovy: UK Clinical Guidance and Weight Loss Results

Transitioning from 10mg Mounjaro to Wegovy is a common consideration for patients seeking to optimise their weight loss treatment in the UK. Both medications are GLP-1 receptor agonists, but they differ in active ingredient (tirzepatide vs semaglutide), dosing schedules, and cost — understanding the clinical equivalence and expected outcomes is essential for making an informed switch under prescriber guidance.

Understanding the 10mg Mounjaro to Wegovy Transition

When switching from 10mg Mounjaro to Wegovy, patients are moving from tirzepatide (a dual GIP/GLP-1 receptor agonist) to semaglutide (a pure GLP-1 receptor agonist). The 10mg dose of Mounjaro represents a mid-range maintenance dose, typically achieved after 16-20 weeks of dose escalation[1]. Wegovy's dosing schedule differs, with a maximum maintenance dose of 2.4mg once weekly, reached through a separate titration protocol starting at 0.25mg[2].

There is no direct milligram-for-milligram equivalence between 10mg Mounjaro to Wegovy because the medications work through different receptor mechanisms and have distinct pharmacokinetic profiles. Clinical guidance from UK prescribers typically recommends starting Wegovy at the initial 0.25mg dose rather than attempting to match the Mounjaro dose numerically, allowing the body to adjust to the new medication and minimise gastrointestinal side effects[3]. This transition must always be supervised by a UK-registered prescriber who can assess individual patient factors including weight loss progress, tolerability, and treatment goals.

Clinical Evidence: 10mg Mounjaro to Wegovy Weight Loss Outcomes

Patients considering the switch from 10mg Mounjaro to Wegovy often ask about comparative weight loss results. In the SURPASS-2 trial, tirzepatide 10mg demonstrated average weight reductions of 9.5kg (approximately 10% body weight) over 40 weeks in adults with type 2 diabetes[1]. The STEP 1 trial showed that semaglutide 2.4mg (Wegovy's maintenance dose) achieved average weight loss of 14.9% of initial body weight over 68 weeks in adults without diabetes[2].

When transitioning from 10mg Mounjaro to Wegovy, UK clinical experience suggests that patients who have already achieved significant weight loss on Mounjaro may experience continued, though potentially slower, weight reduction on Wegovy. The transition period itself — typically 4-8 weeks while titrating Wegovy from 0.25mg to the maintenance dose — may see a temporary plateau in weight loss before resuming a downward trend[4]. Individual results vary based on adherence to lifestyle modifications, baseline metabolic factors, and duration on each medication.

Expected Timeline for Wegovy After 10mg Mounjaro

After discontinuing 10mg Mounjaro, UK prescribers typically recommend waiting 5-7 days before starting Wegovy at 0.25mg, allowing tirzepatide to clear from the system and reducing the risk of overlapping side effects. The Wegovy dose escalation schedule then progresses monthly: 0.25mg for 4 weeks, 0.5mg for 4 weeks, 1mg for 4 weeks, 1.7mg for 4 weeks, and finally 2.4mg maintenance[2]. Patients transitioning from 10mg Mounjaro to Wegovy should expect the full dose titration to take approximately 16-20 weeks, during which weight loss may continue at a rate of 0.5-1kg per week, subject to individual response and prescriber assessment.

Comparing 10mg Mounjaro to Wegovy: Efficacy and Tolerability

The decision to switch from 10mg Mounjaro to Wegovy in the UK often hinges on efficacy, side effect profile, and cost considerations. Tirzepatide's dual receptor mechanism (GIP and GLP-1) has shown superior weight loss in head-to-head trials compared to semaglutide, with the SURPASS-2 study demonstrating greater reductions in HbA1c and body weight with tirzepatide 10mg and 15mg versus semaglutide 1mg[1]. However, Wegovy at 2.4mg — a higher dose than the 1mg used in that comparison — has demonstrated robust weight loss outcomes in its own right.

Tolerability profiles are similar between the two medications when transitioning from 10mg Mounjaro to Wegovy, with nausea, diarrhoea, and constipation being the most common gastrointestinal side effects reported in clinical trials[2][3]. Some UK patients report that the switch to Wegovy offers improved tolerability if they experienced persistent nausea on Mounjaro, though this is highly individual. The slower dose escalation with Wegovy may provide better gastrointestinal adaptation for patients who found the Mounjaro titration schedule challenging.

Treatment Active Ingredient Maintenance Dose Frequency Starting Price
Mounjaro Tirzepatide 10mg-15mg Once weekly From £245.00
Wegovy Semaglutide 2.4mg Once weekly From £89.00
Saxenda Liraglutide 3mg Once daily From £68.00
Wegovy Oral Tablets Semaglutide (oral) 14mg Once daily From £83.00

Practical Guidance for the 10mg Mounjaro to Wegovy Switch in the UK

UK patients switching from 10mg Mounjaro to Wegovy should work closely with their prescriber to create a personalised transition plan. Key practical considerations include timing the switch to avoid disruption to weight loss momentum, managing any withdrawal or adaptation symptoms during the changeover period, and maintaining consistent lifestyle interventions (calorie reduction and physical activity) throughout the transition[4].

At Cured Pharmacy, our UK-registered clinical team provides free online consultations to assess suitability for transitioning from 10mg Mounjaro to Wegovy. The consultation takes under 3 minutes and ensures that the switch is clinically appropriate based on your weight loss history, current health status, and treatment goals. All prescriptions are issued by UK-registered prescribers following MHRA and NICE guidelines, with genuine UK-licensed medications dispensed from our GPhC-registered pharmacy (9012511).

Monitoring Weight Loss During the 10mg Mounjaro to Wegovy Transition

Effective monitoring during the switch from 10mg Mounjaro to Wegovy includes weekly weight measurements, tracking of side effects, and regular prescriber check-ins at each dose escalation. UK clinical guidance recommends continuing the medication only if at least 5% body weight loss is achieved within 12 weeks of reaching the maintenance dose, and 10% loss by 6 months[3]. Patients should also monitor for signs of dehydration, gallbladder issues, or changes in blood glucose (particularly if diabetic), reporting any concerns to their healthcare provider immediately.

Cost Comparison: 10mg Mounjaro to Wegovy UK Pricing

Cost is a significant factor when considering the transition from 10mg Mounjaro to Wegovy in the UK. At Cured Pharmacy, Mounjaro is available from £225.00 per month, whilst Wegovy starts from £225.00 per month, representing substantial savings for patients making the switch. Both medications require ongoing monthly prescriptions, and the total cost of treatment should be considered alongside clinical efficacy and individual response.

Cured Pharmacy offers the cheapest UK price on both Mounjaro and Wegovy, with transparent upfront pricing displayed before consultation. New patients can Save £20 off their first order with code Weightlossnew, and our lowest price guarantee ensures you won't find these medications cheaper elsewhere in the UK. All prices include the clinical consultation, prescription, and discreet next-day delivery across the UK.

Who Should Consider Switching from 10mg Mounjaro to Wegovy?

The decision to switch from 10mg Mounjaro to Wegovy should be based on clinical factors rather than cost alone. Suitable candidates include patients who have achieved their target weight on Mounjaro and wish to transition to a more cost-effective maintenance option, those experiencing persistent side effects on tirzepatide who may tolerate semaglutide better, or patients for whom Mounjaro is temporarily unavailable due to UK supply constraints[4].

Conversely, patients who are still actively losing weight on 10mg Mounjaro and tolerating it well may be advised to continue their current treatment, particularly if planning to escalate to the 12.5mg or 15mg doses for additional weight loss. UK prescribers will assess each case individually, considering weight loss trajectory, metabolic parameters, side effect burden, and patient preference. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team ensure every transition from 10mg Mounjaro to Wegovy is evidence-based and aligned with MHRA guidance.

Long-Term Maintenance: Wegovy After 10mg Mounjaro Success

For patients who have successfully reached their weight loss goals on 10mg Mounjaro, transitioning to Wegovy can serve as a long-term maintenance strategy. Clinical data suggests that continued GLP-1 receptor agonist therapy is necessary to maintain weight loss, with significant weight regain observed upon discontinuation[2]. Wegovy's lower cost compared to higher-dose Mounjaro makes it an attractive option for sustained weight management in the UK, subject to ongoing prescriber review and adherence to lifestyle modifications that support long-term metabolic health.

Scientific References

  1. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
  4. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & STEP 4 Investigators. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the equivalent Wegovy dose to 10mg Mounjaro?
There is no direct milligram equivalent between 10mg Mounjaro and Wegovy due to different receptor mechanisms. UK prescribers recommend starting Wegovy at 0.25mg and titrating to the 2.4mg maintenance dose over 16-20 weeks, regardless of prior Mounjaro dose.
Will I lose more weight switching from 10mg Mounjaro to Wegovy?
Weight loss outcomes when switching from 10mg Mounjaro to Wegovy vary individually. Clinical trials show tirzepatide may produce slightly greater weight loss than semaglutide, but patients already at a lower weight on Mounjaro may experience continued gradual loss on Wegovy with adherence to lifestyle changes.
How long should I wait between stopping 10mg Mounjaro and starting Wegovy?
UK clinical guidance typically recommends waiting 5-7 days after the last 10mg Mounjaro injection before starting Wegovy at 0.25mg, allowing tirzepatide to clear and reducing the risk of overlapping side effects. Always follow your prescriber's specific instructions.
Is the transition from 10mg Mounjaro to Wegovy safe?
Switching from 10mg Mounjaro to Wegovy is safe when supervised by a UK-registered prescriber who can monitor for side effects and adjust the titration schedule. Both medications are MHRA-licensed GLP-1 receptor agonists with similar safety profiles, though individual tolerability may vary.
Why is Wegovy cheaper than Mounjaro in the UK?
Wegovy is cheaper than Mounjaro in the UK due to longer market availability, different manufacturing costs, and competitive pricing strategies. At Cured Pharmacy, Wegovy starts from £225.00 compared to Mounjaro from £225.00, making it a cost-effective option for long-term weight management.
Can I switch back to Mounjaro if Wegovy doesn't work after stopping 10mg Mounjaro?
Yes, patients can switch back to Mounjaro if Wegovy does not provide adequate weight loss or is poorly tolerated, subject to prescriber approval. The return to Mounjaro would follow the standard dose escalation protocol starting at 2.5mg, not immediately resuming 10mg.
Will I regain weight during the 10mg Mounjaro to Wegovy transition?
Some patients experience a temporary weight loss plateau during the transition from 10mg Mounjaro to Wegovy while titrating the new medication, but significant weight regain is uncommon if lifestyle modifications are maintained. Continued calorie restriction and physical activity are essential throughout the switch.
Do I need a new prescription to switch from 10mg Mounjaro to Wegovy?
Yes, switching from 10mg Mounjaro to Wegovy requires a new prescription from a UK-registered prescriber. At Cured Pharmacy, our free online consultation (under 3 minutes) assesses suitability for the switch and issues a Wegovy prescription if clinically appropriate, with next-day UK delivery available.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.